Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

12.60
+0.35002.86%
Post-market: 13.370.7700+6.11%19:54 EDT
Volume:437.53K
Turnover:5.44M
Market Cap:622.67M
PE:-3.45
High:12.63
Open:12.25
Low:11.96
Close:12.25
Loading ...

JMP Securities Initiates KalVista Pharmaceuticals at Market Outperform With $19 Price Target

MT Newswires Live
·
31 Jan

Optimistic Buy Rating for KalVista Pharmaceuticals Amid Promising Launch of Sebetralstat

TIPRANKS
·
31 Jan

KalVista Says Japan Health Ministry Grants Orphan Drug Designation to Sebetralstat

MT Newswires Live
·
21 Jan

KalVista granted orphan drug designation for sebetralstat by MHLW

TIPRANKS
·
21 Jan

Kalvista Announces Orphan Drug Designation and Nda Submission for Sebetralstat in Japan for Hereditary Angioedema

THOMSON REUTERS
·
21 Jan

KalVista Announces Orphan Drug Designation and NDA Submission for Sebetralstat in Japan for Hereditary Angioedema

Business Wire
·
21 Jan

TD Cowen Sticks to Its Buy Rating for KalVista Pharmaceuticals (KALV)

TIPRANKS
·
07 Jan

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires Live
·
19 Dec 2024

KalVista Pharmaceuticals' Sebetralstat Poised to Disrupt Acute HAE Market With Oral Advantage, BofA Says

MT Newswires Live
·
18 Dec 2024

BofA Securities Initiates KalVista Pharmaceuticals at Buy With $22 Price Target

MT Newswires Live
·
18 Dec 2024

BRIEF-Kalvista Appoints Jeb Ledell As Chief Operating Officer

Reuters
·
16 Dec 2024

Kalvista Appoints Jeb Ledell as Chief Operating Officer

THOMSON REUTERS
·
16 Dec 2024

KalVista Appoints Jeb Ledell as Chief Operating Officer

Business Wire
·
16 Dec 2024

Kalvista Pharmaceuticals Inc : Jefferies Cuts Target Price to $33 From $35

THOMSON REUTERS
·
09 Dec 2024

KalVista price target lowered to $33 from $35 at JonesResearch

TIPRANKS
·
07 Dec 2024

Analysts Are Bullish on These Healthcare Stocks: Zynex (ZYXI), KalVista Pharmaceuticals (KALV)

TIPRANKS
·
06 Dec 2024